Mark L. Zangardi
- Oncology top 10%
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 3
- Neutropenia and Cancer Infections 2
- Genetics top 10%
-
- Advanced Breast Cancer Therapies 7
-
- Pharmaceutical Practices and Patient Outcomes 2
-
- Breast Cancer Treatment Studies 3
-
- Delphi Technique in Research 1
Mark L. Zangardi
14 papers receiving 389 citations
Peers
Comparison fields: 5 of 54
- Oncology 242
- Genetics 87
- Pulmonary and Respiratory Medicine 240
- Family Practice 13
- Geriatrics and Gerontology 22
Countries citing papers authored by Mark L. Zangardi
This map shows the geographic impact of Mark L. Zangardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Zangardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Zangardi more than expected).
Fields of papers citing papers by Mark L. Zangardi
This network shows the impact of papers produced by Mark L. Zangardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Zangardi. The network helps show where Mark L. Zangardi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark L. Zangardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2020 | 3 | |
| 3 | 2019 | 26 | |
| 4 | 2019 | 126 | |
| 5 | 2019 | 1 | |
| 6 | 2019 | 3 | |
| 7 | 2018 | 1 | |
| 8 | 2018 | 8 | |
| 9 | 2018 | 28 | |
| 10 | 2017 | 63 | |
| 11 | 2017 | 6 | |
| 12 | A Taxing Consequence: Taxane Acute Pain Syndrome | 2017 | 1 |
| 13 | 2017 | 7 | |
| 14 | 2017 | 120 |
About Mark L. Zangardi
Mark L. Zangardi is a scholar working on Geriatrics and Gerontology, Family Practice, Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 14 papers that have together received 396 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer-related Molecular Pathways (3 papers), Neutropenia and Cancer Infections (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Delphi Technique in Research (1 paper). The work is most often cited by research in Oncology (242 citations), Genetics (87 citations), Pulmonary and Respiratory Medicine (240 citations), Family Practice (13 citations) and Geriatrics and Gerontology (22 citations). Mark L. Zangardi has collaborated with scholars based in United States and Saudi Arabia. Frequent co-authors include Aditya Bardia, Laura M. Spring, Seth A. Wander, Beverly Moy, Gayle C. Blouin, Dejan Juric, Jennifer S. Temel, Margaret Ruddy, Steven J. Isakoff and Aiko Nagayama. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Current Oncology Reports, Cancer Research and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.